IL49763A - 16beta-methyl-9,11-epoxy-17alpha-hydroxy-1,4-pregnadiene-3,20-dione and its preparation - Google Patents

16beta-methyl-9,11-epoxy-17alpha-hydroxy-1,4-pregnadiene-3,20-dione and its preparation

Info

Publication number
IL49763A
IL49763A IL49763A IL4976370A IL49763A IL 49763 A IL49763 A IL 49763A IL 49763 A IL49763 A IL 49763A IL 4976370 A IL4976370 A IL 4976370A IL 49763 A IL49763 A IL 49763A
Authority
IL
Israel
Prior art keywords
methyl
dione
pregnadiene
hydroxy
epoxy
Prior art date
Application number
IL49763A
Other languages
Hebrew (he)
Original Assignee
Villax I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Villax I filed Critical Villax I
Publication of IL49763A publication Critical patent/IL49763A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Table Devices Or Equipment (AREA)

Abstract

1328998 Betamethasone and esters thereof I VILLAX 1 Dec 1970 [13 Dec 1969] 56961/70 Heading C2U The invention comprises (A) betamethasone 21-palmitate: and (B) a process for preparing betamethasone (I) and 21-esters thereof (Ia) from 16#-methyl-17α-hydroxypregna-1,4,9(11)- triene-3,20-dione (II) by the sequence. II#9α - bromo - 16#-methyl-11#,17α-dihydroxypregna - 1,4-diene-3,20-dione#9α,11α-epoxy-16#- methyl - 17α - hydroxypregna - 1,4 - diene - 3,20- dione # 9α - fluoro - 16# - methyl - 11#,17α- dihydroxypregna - 1,4 - diene - 3,20 - dione # 9α- fluoro - 16# - methyl - 11#,17α - dihydroxy - 21,21- diiodopregna - 1,4 - diene - 3,20 - dione # Ia # I, each step being performed under specified conditions. Specified betamethasone 21-esters are the acetate, valerate, isovalerate, palmitate, (hydrogen succinate) and (sodium succinate). [GB1328998A]

Description

49763/2 The present invention relates to 16 £-methyl-9,ll-epoxy-17 -hydroxy-1 ,4-pregnadiene-3,20-dione of the formula: and to a process for the production of same, The above novel compound is a valuable intermediate in the synthesis of various 16 ^ -methyl corticosteroids, and especially in the process for the production of 16 ^ -methyl -9 a -fluoro-11 ^ ,17a -21-trihydroKy-l, -pregnadiene-3,'20-dione and its acylates, which is described and claimed in copending patent application No, 35823 from which the present patent application has been ftvided out.
The starting compound of the process of the present invention, namely 16^ -methyl-17-hydro>¾-l ,4,9(11 )-pregna-triene-3,20-dione of the formula: r Analysis $ CggHg^O^B = ^37.4 Calculated I Br 18.26$ Found t 18.37$ 2 ) 85.3 of the crude product obtained in the previous example is suspended in 1.011 litres methanol, 67k.3 ml chloroform is added, followed by the drop-wise addition of 200.28 ml of a normal solution of sodium hydroxide, during 25 minutes, under stirring and nitrogen atmosphere at a temperature comprised between o° and +3C. After stirring for 3 hours the reaction mixture is neutralized with 50$ aqueous acetic acid and concentrated under vacuum until a crystalline slurry is obtained. The product is then precipitated by addition of 1.390 ml of water and ice, yielding 6¾. ¾ g. of the desired new product

Claims (8)

49763/2 WHAT IS CLAIMED IS:
1. 16 ^ -methyl -9,11 -epoxy-T7 a-hydroxy-l ,4-pregnadiene- 3,20-dione of the formula:
2. A process for the production of 16 ^ -methyl-9,11-epoxy-17a -hydroxy-! ,4-pregnadiene-3,20-dione which comprises reacting 16 g-methyl-17a -hydroxy-1 ,4,9(ll)-pregnatriene-3,20-dione with a bromi nation agent in the presence of aqueous perchloric acid and an inert solvent to yield 16 g-methyl-9a -bromo-Πρ ,17a -dihydroxy-1 ,4-pregnadiene-3,20-dione, and dehydrobromi nat ng this intermediate with an organic or inorganic base in an inert solvent to yield the desired 9(ll)-epoxide.
3. A process according to claim 2, wherein the brominating agent is N-bromo-succinimide or N-bromoacetamide.
4. A process according to claim 2 or 3, wherein the inert solvent is dioxane or tetrahydrofuran.
5. A process according to any of claims 1 to 4, wherein the first step is effected at a temperature of from )-15°C to +35°C.
6. A process according to any of claims 2 to 5, wherein the dehydrobromi nation is effected in an aqueous or a methanolic solution of potassium hydroxide or sodium hydroxide.
7. · A proce^ss according to any of claims 2 to 5» wherein the dehydrobromination is effected by sodium methoxide in an inert solvent*
8. A process for the production of the 9(ll )-epoxides defined in claim 1, substantially as hereinbefore described and with reference to the example.
IL49763A 1969-12-13 1970-12-10 16beta-methyl-9,11-epoxy-17alpha-hydroxy-1,4-pregnadiene-3,20-dione and its preparation IL49763A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT5292369 1969-12-13

Publications (1)

Publication Number Publication Date
IL49763A true IL49763A (en) 1977-08-31

Family

ID=20081704

Family Applications (3)

Application Number Title Priority Date Filing Date
IL49763A IL49763A (en) 1969-12-13 1970-12-10 16beta-methyl-9,11-epoxy-17alpha-hydroxy-1,4-pregnadiene-3,20-dione and its preparation
IL35823A IL35823A (en) 1969-12-13 1970-12-10 Process for the preparation of 16beta-methyl-9alpha-fluoro-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione and its 21-acylates
IL49763A IL49763A0 (en) 1969-12-13 1976-06-10 Novel 9,11-epoxy-pregnadienes and their preparation

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL35823A IL35823A (en) 1969-12-13 1970-12-10 Process for the preparation of 16beta-methyl-9alpha-fluoro-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione and its 21-acylates
IL49763A IL49763A0 (en) 1969-12-13 1976-06-10 Novel 9,11-epoxy-pregnadienes and their preparation

Country Status (15)

Country Link
US (1) US3792046A (en)
JP (3) JPS508080B1 (en)
AT (1) AT304774B (en)
BE (1) BE760236A (en)
CA (1) CA932321A (en)
CH (1) CH551395A (en)
DE (1) DE2059050A1 (en)
DK (1) DK130991B (en)
ES (1) ES386385A1 (en)
FR (1) FR2081356B1 (en)
GB (1) GB1328998A (en)
IL (3) IL49763A (en)
NL (1) NL166694C (en)
NO (1) NO136049C (en)
ZA (1) ZA708393B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58212359A (en) * 1982-05-25 1983-12-10 マグネツト・モ−トル・ゲゼルシヤフト・フユア・マグネツトモ−トリツシエ・テクニ−ク・ミツト・ベシユレンクテル・ハフツンク Rotary electric machine
JPS6261175U (en) * 1985-10-02 1987-04-16
JPS62135570U (en) * 1986-02-19 1987-08-26
JP2004536088A (en) * 2001-06-18 2004-12-02 ファルマシア・アンド・アップジョン・カンパニー Production method of 11β, 17α, 21-trihydroxy-6α-methylpregna-1,4-diene-3,20-dione 21-acetate
US20040006240A1 (en) * 2001-06-18 2004-01-08 Pearlman Bruce Allen Process to prepare 11beta,17alpha ,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate
CN101555268B (en) * 2009-05-21 2011-11-30 广西万德药业股份有限公司 Preparation method for glucocorticoid 9, 11 epoxy intermediate product
CN102304163A (en) * 2011-07-11 2012-01-04 浙江仙居仙乐药业有限公司 Fluorous synthesis method of betamethasone
CN104945464B (en) * 2015-04-17 2016-10-26 浙江仙居仙乐药业有限公司 A kind of synthetic method of betamethasone epoxy hydrolysate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274397A (en) * 1958-12-16 1961-10-27 Chimiotherapie Lab Franc Process for the preparation of 9alpha-fluoro 16alpha-methyl delta1, 4-pregnadienes derivatives
FR1243528A (en) * 1959-08-05 1960-10-14 Chimiotherapie Lab Franc Process for the acetoxylation of steroids in 21 via diiodinated derivatives

Also Published As

Publication number Publication date
IL35823A (en) 1977-08-31
ZA708393B (en) 1972-07-26
DK130991C (en) 1975-12-08
CH551395A (en) 1974-07-15
IL35823A0 (en) 1971-02-25
BE760236A (en) 1971-05-17
FR2081356A1 (en) 1971-12-03
NO136049B (en) 1977-04-04
FR2081356B1 (en) 1976-09-17
DE2059050A1 (en) 1972-04-06
GB1328998A (en) 1973-09-05
US3792046A (en) 1974-02-12
IL49763A0 (en) 1976-08-31
NL7017904A (en) 1971-06-15
AT304774B (en) 1973-01-25
NL166694B (en) 1981-04-15
JPS5721279B1 (en) 1982-05-06
NL166694C (en) 1981-09-15
ES386385A1 (en) 1973-03-16
NO136049C (en) 1977-07-13
JPS508080B1 (en) 1975-04-01
DK130991B (en) 1975-05-12
JPS5721280B1 (en) 1982-05-06
CA932321A (en) 1973-08-21

Similar Documents

Publication Publication Date Title
AU632864B2 (en) Process for the manufacture of budesonide
HU188067B (en) Process for preparing delta 17/20/21-substituted steroids
US4036831A (en) Trimethyl siloxane steroid intermediates
IL49763A (en) 16beta-methyl-9,11-epoxy-17alpha-hydroxy-1,4-pregnadiene-3,20-dione and its preparation
Nitta et al. The syntheses of the corticoid side chain. I. An improved method for the preparation of 17. ALPHA.-hydroxyprogesterone from androst-4-ene-3, 17-dione.
US3839369A (en) Process for the production of delta4,9(11),16-3,20-diketo steroids
US3682983A (en) Preparation of {66 {11 {11 -17 ethinyl steroids
US3444216A (en) Process for the oxidation of primary and secondary alcohols
US3127396A (en) Chj co
US2769824A (en) Hydroxylation of delta-pregnenes
US4956482A (en) Process for the preparation of pregnane derivatives
US2963498A (en) Dehydro derivatives of 11-oxygenated 17alpha-(lower alkanoyl)-oxy-9alpha-halopregnane-3, 20-diones
JPH06104679B2 (en) Novel steroid diols, pharmaceutical compositions containing them, and methods for their preparation
US3064017A (en) Preparation viii
US2702290A (en) Method for preparation of cyclopentanophenanthrene derivatives
US3026320A (en) Derivatives of cortisone and hydrocortisone
US3255218A (en) 17(20)-enol-21-aldehydes of the pregnane series
US3528999A (en) Substituted methylene steroids and their preparation
US3178412A (en) Process for the production of 6beta-fluoro steroids
US2734907A (en) Process for the production of
US3079407A (en) 16-trihalomethyl steroids
US2773059A (en) Steroid alpha-halo ketals
US3845040A (en) Protection of steroid carbonyl group by enolisation
US3697510A (en) Novel preparation of pregnanes
US2813882A (en) delta-3, 20-diketo-17-hydroxy-11, 21-bis oxygenated-pregnadiene compounds and processes of preparing the same